Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
234.7 BRL | +0.35% | +0.35% | +20.06% |
May. 29 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
May. 29 | Nicotine-like chemicals in U.S. vapes may be more potent than nicotine, FDA says | RE |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Its low valuation, with P/E ratio at 9.04 and 8.77 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company has a low valuation given the cash flows generated by its activity.
- This company will be of major interest to investors in search of a high dividend stock.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+20.06% | 79.44B | - | ||
-6.87% | 63.79B | B | ||
+24.36% | 50.27B | A- | ||
-3.91% | 6.81B | A- | ||
-17.88% | 5.26B | A- | ||
-5.50% | 2.4B | C- | ||
-8.00% | 2.21B | C- | ||
-36.40% | 1.52B | - | ||
-8.45% | 1.23B | D+ | ||
-16.97% | 1.17B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- MO Stock
- MOOO34 Stock
- Ratings Altria Group, Inc.